Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:PRTK

Paratek Pharmaceuticals (PRTK) Stock Price, News & Analysis

Paratek Pharmaceuticals logo

About Paratek Pharmaceuticals Stock (NASDAQ:PRTK)

Advanced Chart

Key Stats

Today's Range
$2.23
$2.23
50-Day Range
$2.17
$2.23
52-Week Range
$1.29
$3.65
Volume
N/A
Average Volume
724,253 shs
Market Capitalization
$127.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PRTK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Paratek Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PRTK Stock News Headlines

[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time could validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Paratek Pharmaceuticals to acquire Optinose in $330M transaction
See More Headlines

PRTK Stock Analysis - Frequently Asked Questions

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) issued its earnings results on Monday, November, 8th. The specialty pharmaceutical company reported ($0.37) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.45) by $0.08. The specialty pharmaceutical company earned $24.45 million during the quarter, compared to analysts' expectations of $22.98 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Paratek Pharmaceuticals investors own include Energy Transfer (ET), Sorrento Therapeutics (SRNE), Micron Technology (MU), Verastem (VSTM), Citius Pharmaceuticals (CTXR), SCYNEXIS (SCYX) and Aurinia Pharmaceuticals (AUPH).

Company Calendar

Last Earnings
11/08/2021
Today
7/09/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:PRTK
Previous Symbol
NASDAQ:TSPT
CIK
1178711
Employees
268
Year Founded
1996

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$63.57 million
Pretax Margin
-35.35%

Debt

Sales & Book Value

Annual Sales
$160.27 million
Price / Cash Flow
N/A
Book Value
($3.08) per share
Price / Book
-0.72

Miscellaneous

Free Float
52,736,000
Market Cap
$127.82 million
Optionable
Optionable
Beta
1.70

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:PRTK) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners